In additional analyses, we did not observe transcriptional downregulation of FANCA, FANCC, FANCD1, FANCD2, FANCE or FANCG mRNA and found no evidence of methylation in the CpG islands of any of these genes in our ovarian cancer cell line panel. This evidence concerns the gene FANCE and ovarian carcinoma.